Stock TRIB TRINITY BIOTECH PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-03 EDT 		5-day change 1st Jan Change
1.802 USD +7.27% Intraday chart for Trinity Biotech plc -1.52% -15.98%
05-03 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower MT
05-02 European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 47.93 21.6 79.64 29.89 37.73 16.39
Enterprise Value (EV) 1 99.99 107.4 156.6 103.2 103.3 80.13
P/E ratio -2.17 x -0.74 x -12.5 x 38.2 x -0.81 x -0.68 x
Yield - - - - - -
Capitalization / Revenue 0.49 x 0.24 x 0.78 x 0.32 x 0.5 x 0.29 x
EV / Revenue 1.03 x 1.19 x 1.54 x 1.11 x 1.38 x 1.41 x
EV / EBITDA 10.8 x 27.6 x 7.62 x 9.78 x -10.9 x -5.6 x
EV / FCF -6.95 x -14.2 x 25 x -133 x -12.2 x -6.24 x
FCF Yield -14.4% -7.03% 4.01% -0.75% -8.2% -16%
Price to Book 1.09 x 4.58 x -35.9 x -93.7 x -17.3 x -0.69 x
Nbr of stocks (in thousands) 4,186 4,180 4,180 4,180 7,622 7,642
Reference price 2 11.45 5.167 19.05 7.150 4.950 2.145
Announcement Date 19-05-14 20-06-15 21-04-30 22-05-02 23-05-16 24-04-30
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 97.04 90.44 102 92.96 74.78 56.83
EBITDA 1 9.262 3.895 20.56 10.55 -9.521 -14.3
EBIT 1 6.705 0.183 18.45 8.901 -10.92 -16.08
Operating Margin 6.91% 0.2% 18.09% 9.57% -14.6% -28.29%
Earnings before Tax (EBT) 1 -23.18 -30 -6.633 0.751 -41.19 -36.93
Net income 1 -22.09 -28.91 -6.388 0.875 -41.01 -24.02
Net margin -22.76% -31.97% -6.26% 0.94% -54.84% -42.26%
EPS 2 -5.284 -6.982 -1.528 0.1871 -6.078 -3.138
Free Cash Flow 1 -14.38 -7.552 6.274 -0.7735 -8.473 -12.83
FCF margin -14.82% -8.35% 6.15% -0.83% -11.33% -22.58%
FCF Conversion (EBITDA) - - 30.51% - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-05-14 20-06-15 21-04-30 22-05-02 23-05-16 24-04-30
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 22 19.52 18.78 - 19.5 18.04 14.83 13.9
EBITDA - - - - - - - -
EBIT 1 2.748 1.687 0.173 - -0.098 -7.809 -3.919 -4.037
Operating Margin 12.49% 8.64% 0.92% - -0.5% -43.3% -26.43% -29.05%
Earnings before Tax (EBT) 1 1.581 -2.45 -12.43 - -8.941 -10.09 -6.316 -18.61
Net income 1 1.321 -1.264 -12.28 -9.706 -8.945 -10.08 -5.809 -5.988
Net margin 6% -6.47% -65.4% - -45.87% -55.89% -39.17% -43.09%
EPS 2 0.3150 -0.3000 -2.500 -1.430 -1.175 -1.325 -0.7600 -0.7800
Dividend per Share - - - - - - - -
Announcement Date 21-12-15 22-04-11 22-06-30 22-11-03 22-12-15 23-03-23 23-07-06 23-10-03
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 52.1 85.8 77 73.3 65.6 63.7
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 5.622 x 22.02 x 3.745 x 6.946 x -6.892 x -4.456 x
Free Cash Flow 1 -14.4 -7.55 6.27 -0.77 -8.47 -12.8
ROE (net income / shareholders' equity) -41.5% -119% -482% -73.2% 3,287% 282%
ROA (Net income/ Total Assets) 2.43% 0.08% 8.82% 4.46% -6.47% -13.3%
Assets 1 -908.3 -35,740 -72.44 19.61 633.9 181.1
Book Value Per Share 2 10.50 1.130 -0.5300 -0.0800 -0.2900 -3.120
Cash Flow per Share 2 7.240 3.640 6.540 6.200 0.8600 0.4800
Capex 1 7.53 2.14 3.21 1.81 1.1 0.8
Capex / Sales 7.76% 2.36% 3.15% 1.95% 1.47% 1.41%
Announcement Date 19-05-14 20-06-15 21-04-30 22-05-02 23-05-16 24-04-30
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
TRINITY BIOTECH PLC Stock Trinity Biotech plc
-15.98% 17.06M
BIOMÉRIEUX Stock bioMérieux
-1.89% 12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.68B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.31% 5.29B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.24B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.6B
VITROLIFE AB Stock Vitrolife AB
-10.02% 2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. TRIB Stock
  4. Financials Trinity Biotech plc